Trial Profile
A phase I study of Cinryze for the treatment of paroxysmal nocturnal haemoglobinuria
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2015
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Adverse reactions; Therapeutic Use
- 27 Jan 2015 New trial record